Reply to: Beyond S100B: The need for new biomarkers in stage III melanoma recurrence detection.

Autor: Jansen MR; University of Groningen, University Medical Center Groningen (UMCG), Department of Surgical Oncology, Hanzeplein 1, 9700 RB, Groningen, the Netherlands; University of Parma, Parma University Hospital, Department of Medicine and Surgery, Via Gramsci 14, 43100, Parma, Italy; Institute of Romagna for the Study of Cancer (IRST IRCSS), Skin Cancer Unit, 47014, Meldola, Italy. Electronic address: m.r.jansen@umcg.nl., Caini S; Institute for Cancer Research, Prevention, and Clinical Network (ISPRO), Cancer Risk Factors and Lifestyle Epidemiology Unit, 50139, Florence, Italy. Electronic address: s.caini@ispro.toscana.it., Stanganelli I; University of Parma, Parma University Hospital, Department of Medicine and Surgery, Via Gramsci 14, 43100, Parma, Italy; Institute of Romagna for the Study of Cancer (IRST IRCSS), Skin Cancer Unit, 47014, Meldola, Italy. Electronic address: ignazio.stanganelli@irst.emr.it., Been LB; University of Groningen, University Medical Center Groningen (UMCG), Department of Surgical Oncology, Hanzeplein 1, 9700 RB, Groningen, the Netherlands. Electronic address: l.b.been@umcg.nl., van Leeuwen BL; University of Groningen, University Medical Center Groningen (UMCG), Department of Surgical Oncology, Hanzeplein 1, 9700 RB, Groningen, the Netherlands. Electronic address: b.l.van.leeuwen@umcg.nl.
Jazyk: angličtina
Zdroj: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Nov; Vol. 50 (11), pp. 108542. Date of Electronic Publication: 2024 Jul 17.
DOI: 10.1016/j.ejso.2024.108542
Abstrakt: Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Databáze: MEDLINE
Externí odkaz: